Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial

Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The NIH site-transition announcement banner is no longer displayed above the 403 Forbidden page.
    Difference
    1%
    Check dated 2026-11-09T13:19:55.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T12:45:34.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A notice announces NIH transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T13:33:47.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T14:11:55.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:20:06.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Version update to Revision: v3.7.0 is shown, and a large block of terms and fields—such as regulatory status, the study drugs, disease/MeSH terms, and key eligibility/outcome descriptors—were removed from the page. This change alters how the study is described and indexed on ClinicalTrials.gov.
    Difference
    19%
    Check dated 2026-09-21T22:20:51.000Z thumbnail image

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.